NO20024578L - Inhibering av angiogenese og tumorvekst - Google Patents

Inhibering av angiogenese og tumorvekst

Info

Publication number
NO20024578L
NO20024578L NO20024578A NO20024578A NO20024578L NO 20024578 L NO20024578 L NO 20024578L NO 20024578 A NO20024578 A NO 20024578A NO 20024578 A NO20024578 A NO 20024578A NO 20024578 L NO20024578 L NO 20024578L
Authority
NO
Norway
Prior art keywords
angiogenesis
inhibition
tumor growth
tumor
growth
Prior art date
Application number
NO20024578A
Other languages
English (en)
Other versions
NO328969B1 (no
NO20024578D0 (no
Inventor
Dale L Boger
David A Cheresh
Original Assignee
Scripps Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Inst filed Critical Scripps Research Inst
Publication of NO20024578D0 publication Critical patent/NO20024578D0/no
Publication of NO20024578L publication Critical patent/NO20024578L/no
Publication of NO328969B1 publication Critical patent/NO328969B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20024578A 2000-03-27 2002-09-24 Forbindelser, sammensetninger og anvendelser derav NO328969B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19226000P 2000-03-27 2000-03-27
PCT/US2001/009756 WO2001072699A1 (en) 2000-03-27 2001-03-27 Inhibition of angiogenesis and tumor growth

Publications (3)

Publication Number Publication Date
NO20024578D0 NO20024578D0 (no) 2002-09-24
NO20024578L true NO20024578L (no) 2002-11-20
NO328969B1 NO328969B1 (no) 2010-06-28

Family

ID=22708924

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20024578A NO328969B1 (no) 2000-03-27 2002-09-24 Forbindelser, sammensetninger og anvendelser derav
NO20024576A NO20024576L (no) 2000-03-27 2002-09-24 Fremgangsmate for a inhibere angiogenese og tumorvekst

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20024576A NO20024576L (no) 2000-03-27 2002-09-24 Fremgangsmate for a inhibere angiogenese og tumorvekst

Country Status (15)

Country Link
EP (2) EP1276713A4 (no)
JP (2) JP2003528140A (no)
KR (2) KR100776185B1 (no)
CN (2) CN1245967C (no)
AU (4) AU5101801A (no)
CA (3) CA2403630C (no)
CZ (2) CZ20023509A3 (no)
HU (2) HUP0301797A3 (no)
MX (2) MXPA02009510A (no)
NO (2) NO328969B1 (no)
PL (2) PL358272A1 (no)
RU (2) RU2276133C2 (no)
SK (2) SK14842002A3 (no)
WO (2) WO2001072297A1 (no)
ZA (2) ZA200208628B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1870980B (zh) 2003-10-23 2010-06-23 大冢制药株式会社 控释无菌阿立哌唑注射剂和方法
BRPI0815382A2 (pt) 2007-07-31 2015-02-10 Otsuka Pharma Co Ltd Métodos para a produção de suspensão de aripiprazol e formulação de secagem por congelamento

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8311286D0 (en) * 1983-04-26 1983-06-02 Searle & Co Carboxyalkyl peptide derivatives
JPH05125029A (ja) 1991-11-06 1993-05-21 Yamanouchi Pharmaceut Co Ltd 新規なアミド化合物又はその塩
GB9308695D0 (en) * 1993-04-27 1993-06-09 Celltech Ltd Peptidyl derivatives
GB9405076D0 (en) * 1994-03-16 1994-04-27 Inst Of Ophtalmology A medical use of matrix metalloproteinase inhibitors
AUPO104496A0 (en) * 1996-07-17 1996-08-08 Biomolecular Research Institute Limited Angiogenic inhibitory compounds
JP2002514180A (ja) * 1996-09-04 2002-05-14 ワーナー―ランバート・コンパニー マトリックスメタロプロテイナーゼを阻害するための化合物およびその方法
JP2001512441A (ja) * 1997-02-07 2001-08-21 ザ スクリップス リサーチ インスティテュート コンビナトリアルライブラリーの収束的合成
IL138297A0 (en) * 1998-03-27 2001-10-31 Genentech Inc Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders

Also Published As

Publication number Publication date
EP1272173A1 (en) 2003-01-08
CA2403630C (en) 2009-05-26
RU2269339C2 (ru) 2006-02-10
AU2001249499B2 (en) 2005-04-21
AU2001251018B2 (en) 2005-12-01
HUP0301621A3 (en) 2009-06-29
NO20024576D0 (no) 2002-09-24
EP1276713A4 (en) 2006-05-03
EP1272173A4 (en) 2006-05-03
CZ20023510A3 (cs) 2003-03-12
CN1429106A (zh) 2003-07-09
PL205134B1 (pl) 2010-03-31
PL358272A1 (en) 2004-08-09
SK14842002A3 (sk) 2003-04-01
NO20024576L (no) 2002-11-20
CA2403630A1 (en) 2001-10-04
JP2003528850A (ja) 2003-09-30
RU2276133C2 (ru) 2006-05-10
SK14852002A3 (sk) 2003-06-03
WO2001072699A1 (en) 2001-10-04
MXPA02009504A (es) 2003-05-21
CN1441777A (zh) 2003-09-10
KR20020084258A (ko) 2002-11-04
NO328969B1 (no) 2010-06-28
CA2403871A1 (en) 2001-10-04
JP2003528140A (ja) 2003-09-24
MXPA02009510A (es) 2003-05-21
ZA200208626B (en) 2004-02-16
CA2403871C (en) 2010-05-11
PL366316A1 (en) 2005-01-24
HUP0301797A2 (hu) 2003-09-29
ZA200208628B (en) 2004-02-12
CZ20023509A3 (cs) 2003-06-18
RU2002128751A (ru) 2004-03-10
CN1229339C (zh) 2005-11-30
HUP0301621A2 (hu) 2003-09-29
CN1245967C (zh) 2006-03-22
HUP0301797A3 (en) 2010-09-28
KR20020091156A (ko) 2002-12-05
KR100776185B1 (ko) 2007-11-16
WO2001072297A1 (en) 2001-10-04
NO20024578D0 (no) 2002-09-24
CA2659030A1 (en) 2001-10-04
AU4949901A (en) 2001-10-08
EP1276713A1 (en) 2003-01-22
AU5101801A (en) 2001-10-08
KR100767616B1 (ko) 2007-10-18

Similar Documents

Publication Publication Date Title
EP1097165A4 (en) NEW INHIBITORS OF ANGIOGENESIS AND TUMOR GROWTH
NO20030725D0 (no) Terapeutisk kombinasjon av CETP-inhibitor og atorvastatin
NO20024627D0 (no) Inhibering av cyklooksygenase-1-aktivitet
NO20025792L (no) Kinazolinderivater for behandling av tumorer
NO20021382L (no) Fremgangsmåter og mikroorganismer for fremstilling av panto- forbindelser
NO20025377L (no) Fremgangsmate for fremstilling av dihydroksyestere og derivater derav
AU2600800A (en) Promotion or inhibition of angiogenesis and cardiovascularization
NO20024775D0 (no) Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
NO20024486L (no) Forbedret behandling av neovaskularisering
NO20023837D0 (no) Modulering av bendannelse
AU2596700A (en) Promotion or inhibition of angiogenesis and cardiovascularization
NO20024777L (no) Kinolinyl-piperidin-4-yliden-metyl-benzamid derivater til behandling av smerte
NO20024776L (no) Hydroksyfenyl-piperazinyl-metyl-benzamid derivater til behandling av smerte
NO20024236D0 (no) Behandling av psoriasis
NO20030978L (no) Behandling av urindysfunksjon
NO20024578D0 (no) Inhibering av angiogenese og tumorvekst
IS6707A (is) Efnablanda til forvarna og meðhöndlunar á krabbameini
PT1272456E (pt) Inibidores de angiogenese de hidrazida e alcoxiamida
NO20004109L (no) Stabilisering av formasjoner
NO20014845D0 (no) Anvendelse av arylalkanoylpyridaziner
NO20042126L (no) Syntese av 2-aralkoksyadenosiner og 2-alkoksyadenosiner
AU2001268670A1 (en) Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of erk-5
FI20001451A (fi) Lasintyöstöterien kunnostus
FI6139U1 (fi) Käyttäjäkeskeisen fysioterapian toteuttaminen
NO20014454D0 (no) Konstruksjon og anvendelse av samme

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees